IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1570
0.00 (0.00%)
At close: Feb 20, 2026
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €1.04 million as of February 20, 2026. Its market cap has decreased by -69.22% in one year.
Market Cap
1.04M
Enterprise Value
-264.55K
Revenue
6.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.16
Market Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 1.04M, a decrease of -96.96%. That is a compound annual growth rate of -19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.04M | 18.05% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aelis Farma | 18.83M |
| GenSight Biologics | 18.06M |
| Poxel | 14.70M |
| NFL Biosciences | 13.71M |
| Plant Advanced Technologies | 9.36M |
| Oncodesign Precision Medicine Société anonyme | 9.04M |
| TME Pharma | 7.15M |
| Quantum Genomics Société Anonyme | 5.03M |